XYMAX REIT Investment (TSE:3488) delivered a 9.1% increase in earnings this year, building on a robust 5.5% annual growth rate over the past five years. Net profit margins ticked up to 50% from 48.5% last year. High-quality earnings further…
Category: 6. Business
-
Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study
– Late-Breaking ASCENT-03 Data Simultaneously Presented at ESMO 2025 and Published in The New England Journal of Medicine –
– With Two Positive Phase 3 Trials, Trodelvy Has Potential as the First and Only ADC to be a Backbone…
Continue Reading
-
Moody's: Ceasefire credit positive but risks are high
The agency’s rating for Israel remains at Baa1 with a negative outlook, although it has upgraded its economic forecast.
Continue Reading
-
FLAURA2 Trial: Osimertinib Plus Chemotherapy Improves Overall Survival Across Prognostic Subgroups in EGFR-Mutated Advanced NSCLC — Presented at ESMO 2025
The Phase 3 FLAURA2 trial (NCT04035486) continues to strengthen the role of combination therapy in the first-line management of EGFR-mutated (EGFRm) advanced non–small cell lung cancer (NSCLC). At ESMO 2025, investigators…
Continue Reading
-
ZOOZ Purchases 88 More Bitcoin, Growing Its Total Bitcoin Treasury to 942 Bitcoin
This is another milestone in strengthening ZOOZ’s position as one of the first companies globally to execute a long-term institutional Bitcoin treasury strategy
Continue Reading
-
“On the Fence About Buying Drone Companies that Aren’t Making Money”
Red Cat Holdings, Inc. (NASDAQ:RCAT) is one of the stocks Jim Cramer was focused on recently. When a caller asked about the stock during the lightning round, Cramer said:
“Okay, so this is a Ben Stoto favorite, not really. It’s a drone…
Continue Reading
-
Assessing Futu Holdings (NasdaqGM:FUTU) Valuation After a 100% Year-to-Date Share Price Surge
Futu Holdings (NasdaqGM:FUTU) shares have seen a steady climb this year, with the stock up over 100% year-to-date. Many investors are now reviewing its recent performance and growth numbers for insights into what might come next.
See our…
Continue Reading
-
ADC Improves Outcomes for Patients with Advanced Triple-Negative Breast Cancer Who are Ineligible for Immune Checkpoint Inhibitors
Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan compared…
Continue Reading
-
Reassessing Valuation as Soracaya Project Advances Toward Full Production
Santacruz Silver Mining (TSXV:SCZ) just took a big step forward at its Soracaya Project in Bolivia. The company is moving closer to full production by advancing its permitting process and finalizing the preliminary mine plan.
See our latest…
Continue Reading
